Searchable abstracts of presentations at key conferences in endocrinology

ea0025p351 | Thyroid | SFEBES2011

Thyroid dysfunction in patients receiving interferon treatment for hepatitis C: an audit

Sugunendran Suma , Verghese Jeanny , Aye Mo , Sathyapalan Thozhukat , Abouda George , Mohamed Kamrudeen

Aims and objective: Pegylated interferon is widely used in the treatment of hepatitis C. Thyroid dysfunction (TD) is a well recognised side effect of interferon treatment. As the use of interferon therapy in hepatitis C is on the rise, we conducted an audit to determine its prevalence and to formulate local guidelines for the monitoring and management of thyroid dysfunction in these patients.Methods: A case note based retrospective audit of all patients ...